oestradiol
Phase 3Small molecule
oestradiol is one of 91 small molecule programs targeting Treatment. It is currently in Phase 3.
2
Indications
4
Total Trials
1
Active Trials
90
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
350 competitors in Treatment
#DrugCompanyPhaseTrials
1oestradiol
UUniversity Hospital, Toulouse
Phase 3
Biltricide
BayerPreclinical
Theo-Dur
PfizerPreclinical
Levulan
Sun Pharmaceutical Industries, Inc.Preclinical
Lamprene
NovartisPreclinical
Emtriva
GileadPreclinical
Niclocide
BayerPreclinical
Minipress
PfizerPreclinical
Foscavir
CClinigen, Inc.
Preclinical
Intuniv
PPromius Pharma, LLC
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Menopausal Women1 trial
Adenomyosis1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for oestradiol. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 3[1]
- Company
- UUniversity Hospital, Toulouse